This event will empower you with the knowledge and skills needed to identify, diagnose, and manage the multifaceted aspects of Long COVID in clinical practice. Engage with leading experts across specialties who will share the latest!

Tune in to the first live webinar of our three-part 3rd Annual Retinal Disease Hot Topics Webinar series to hear from two leading retina specialists as they discuss the roles of VEGF and Ang-2 in retinal vascular diseases and more!

The goal of this program is to increase the health care professional’s ability to: analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors and identify potential adverse events.

Join us for an engaging live symposium where two leading upper gastrointestinal (GI) cancer experts will explore the latest advances in the management of gastric, gastroesophageal junction, and esophageal cancers (upper GI cancers).

Explore the predominant AKI phenotypes seen in patients with advanced liver disease. Faculty will provide clarity on distinguishing features and clinical relevance to inform the differential diagnosis process.

This program addresses the importance of comprehensive molecular testing in metastatic colorectal cancer (mCRC) and outlines recent updates in clinical practice guideline recommendations for various molecular tests in mCRC.

After the session, learners can explain the pathological processes of the common forms of dementia, summarize epidemiological trends of dementia in Tennessee/USA, and know the benefits of proactive screening as it relates to health outcomes.

After the session, learners can articulate the typical treatment approach to dementia medications, compare different medication treatment approach, and justify when to discontinue medication.

Join us for this live webinar, where two expert faculty will delve into the latest clinical evidence and professional guidelines for utilizing CGM.

At the end of this session, learners can describe eligibility criteria for new infusion treatments, predict ARIA risk based on APOE status, and differentiate most appropriate cases for prescribing.